Subscribe to RSS
DOI: 10.4103/ajm.AJM_130_18
Infectious diseases in the era of refugees: Hepatitis A outbreak in Lebanon
Financial support and sponsorship Nil.Abstract
Background: The Syrian crisis has altered the epidemiology of infectious diseases in countries hosting large numbers of refugees. Lebanon witnessed several outbreaks linked to the presence of significant numbers of Syrian refugees, namely, Hepatitis A virus (HAV). We explore the epidemiology of HAV in Lebanon and the impact of the Syrian war during the 2014 outbreak and suggest solutions to prevent and minimize the HAV spread amid the current socioeconomic conditions. Methods: We reviewed all HAV cases reported to the Epidemiologic Surveillance Unit at the Ministry of Public Health between January 2001 and December 2017. Demographics and distribution of Syrian refugees in Lebanon were linked to reports of new HAV cases. Results: A sharp rise in the number of reported HAV cases was observed in Lebanon in 2013, concurrent with the Syrian crisis and influx of refugees. Most cases reported in 2013 and 2014 involved Syrian refugees and their relevant areas of settlement in the Beqaa and North governorates. Conclusion: The influx of refugees strained overburdened sanitary infrastructure and overstretched existing public health services in Lebanon, which led to an increase in the incidence of reported HAV cases. The Lebanese health authorities and the international community need to intensify their efforts in surveillance and prevention of communicable diseases. Providing proper sanitation and free vaccination for affected communities are effective solutions to contain the HAV outbreak. Yet, financial constraints and the need to prioritize in the health budget put HAV-immunization at a lower priority. The Lebanese scenario could be reflective to other countries hosting sizeable numbers of refugees.
Publication History
Article published online:
12 August 2021
© 2018. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. et al. Revisiting leishmaniasis in the time of war: The Syrian conflict and the Lebanese outbreak. Int J Infect Dis 2014; 29: 115-9
- 2 Bell BP, Wasley A, Shapiro CN, Margolis HS. Prevention of hepatitis A through active or passive immunization: Recommendations of the advisory committee on immunization practices [ACIP]. MMWR 1999; 48: i-37
-
3 World Health Organization. Hepatitis A Factsheet; 5 July, 2017. Available from: http://www.who.int/news-room/fact-sheets/detail/ hepatitis-a. [Last accessed on 2018 Jul 25].
- 4 Yayli G, Kiliç S, Ormeci AR. Hepatitis agents with enteric transmission – an epidemiological analysis. Infection 2002; 30: 334-7
- 5 Ghorbani GA, Mahboobi N, Lankarani KB, Alavian SM. Hepatitis a prevention strategies, Haiti case: Should rescuers be immunized. Iran Red Crescent Med J 2010; 12: 221
- 6 Alavi MoghaddamM. Hepatitis A virus: A major global public health problem, especially in developing countries. Hepat Mon 2005; 5: 145-9
- 7 Al RashedRS. Prevalence of hepatitis A virus among Saudi Arabian children: A community-based study. Ann Saudi Med 1997; 17: 200-3
- 8 Khalil M, Al-Mazrou Y, Al-Jeffri M, Al-Howasi S. Childhood epidemiology of hepatitis A virus in Riyadh, Saudi Arabia. Ann Saudi Med 1998; 18: 18-21
- 9 Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000; 18 Suppl 1: S65-7
- 10 Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol Infect 2004; 132: 1005-22
- 11 Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and north Africa region: A new challenge. J Viral Hepat 2014; 12: 605-15
- 12 Kalaajieh W, Rima A, Al KhodayryR. Seroprevalence of hepatitis A antibodies in Lebanese children. Med Mal Infect 2000; 30: 757-61
- 13 Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R. et al. Hepatitis a in Lebanon: A changing epidemiological pattern. Am J Trop Med Hyg 2005; 73: 453-6
- 14 Bizri AR, Nuwayhid IA, Hamadeh GN, Steitieh SW, Choukair AM, Musharrafieh UM. et al. Association between hepatitis A virus and helicobacter pylori in a developing country: The saga continues. J Gastroenterol Hepatol 2006; 21: 1615-21
- 15 Melhem NM, Jaffa M, Zaatari M, Awada H, Salibi NE, Ramia S. et al. The changing pattern of hepatitis A in Lebanese adults. Int J Infect Dis 2015; 30: 87-90
- 16 Burki T. Infectious diseases in Malian and Syrian conflicts. Lancet Infect Dis 2013; 13: 296-7
-
17 United Nations High Commission on Refugees. Syrian Regional Refugee Response; 19 July, 2018. Available from: https://www.data2.unhcr.org/en/situations/syria. [Last accessed on 2018 Jul 25].
- 18 Shamma'a MH, Abu-Samra S, Salameh V, Nassar NT. et al. The significance of anti-HAV in different population sectors in Lebanon: A comparative seroepidemiologic study. Int J Epidemiol 1982; 11: 406-9
-
19 Republic of Lebanon Ministry of Public Health. Epidemiological Surveillance: General Surveillance Data; 2018. Available from: http://www.moph.gov.lb/en/Pages/2/193/epidemiological-surveillance. [Last accessed on 2018 Jul 25].
- 20 Assaf H, Saadeh M. Geostatistical assessment of groundwater nitrate contamination with reflection on DRASTIC vulnerability assessment: The case of the Upper Litani Basin, Lebanon. Water Resour Manag 2009; 23: 775-96
-
21 UNICEF. UNICEF Lebanon: Immunization; 20 May, 2014. Available from: https://www.unicef.org/lebanon/thematic_factsheets.pdf. [Last accessed on 2018 Jul 25].
-
22 United Nations Development Programme. Lebanon Crisis Response Plan (LCRP) 2017-2020; 16 July, 2017. Available from: https://www.reliefweb.int/sites/reliefweb.int/files/resources/2017_2020_LCRP_ENG-1.pdf. [Last accessed on 2018 Jul 25].
-
23 World Health Organization. World Health Assembly Approves Resolution on Hepatitis and Mechanism to Coordinate Noncommunicable Disease Response; 22 May, 2014. Available from: http://www.who.int/mediacentre/news/releases/2014/WHA-20140522/en/. [Last accessed on 2018 Jul 25].
-
24 United States Agency for International Development. USAID Water and Development Strategy 2013-2018; 15 May, 2013. Available from: https://www.usaid.gov/sites/default/files/documents/1865/USAID_Water_Strategy_3.pdf. [Last accessed on 2018 Jul 25].
- 25 Fares Y, Fares J. Neurosurgery in Lebanon: History, development, and future challenges. World Neurosurg 2017; 99: 524-32
-
26 UNICEF. UNICEF in Lebanon and immunization campaigns. Hum Health 2017;38:12-5.
-
27 World Health Organization. World Health Organization Vaccine-Preventable Diseases: Monitoring System 2018 Global Summary; 15 July, 2018. Available from: http://www.apps.who.int/immunization_ monitoring/globalsummary. [Last accessed on 2018 Jul 25].
- 28 Bialek SR, Thoroughman DA, Hu D, Simard EP, Chattin J, Cheek J. et al. Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health 2004; 94: 996-1001
- 29 Blanco FernándezMD, Torres C, Riviello-López G, Poma HR, Rajal VB, Nates S. et al. Analysis of the circulation of hepatitis A virus in Argentina since vaccine introduction. Clin Microbiol Infect 2012; 18: E548-51
- 30 Cui F, Hadler SC, Zheng H, Wang F, Zhenhua W, Yuansheng H. et al. Hepatitis A surveillance and vaccine use in China from 1990 through 2007. J Epidemiol 2009; 19: 189-95